Pressure BioSciences, Inc. (PBIO)
| Market Cap | 7.17M |
| Revenue (ttm) | 2.27M |
| Net Income (ttm) | -6.40B |
| Shares Out | 21.73M |
| EPS (ttm) | -403.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 77,440 |
| Open | 0.380 |
| Previous Close | 0.350 |
| Day's Range | 0.320 - 0.390 |
| 52-Week Range | 0.170 - 2.200 |
| Beta | 0.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PBIO
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also di... [Read more]
Financial Performance
In 2022, PBIO's revenue was $1.73 million, a decrease of -13.63% compared to the previous year's $2.00 million. Losses were -$16.82 million, -51.38% less than in 2021.
Financial StatementsNews
Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform
Beyond Formidable Enhancements for the Food and Beverage Industry, UST Offers Promising Applications in Drug Delivery, Cosmetics, Biotechnology, Agriculture, and Advanced Nanomaterials SOUTH EASTON, M...
Pressure BioSciences' UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores
Novel Results Published in Respected Peer-Reviewed Food Science and Emerging Technologies Journal - Discussions Underway with Beverage Industry Companies SOUTH EASTON, MA / ACCESSWIRE / December 12, 2...
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador
Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of the Agreement. "Valor CBD" Topical Spray Now Available on the VST Website.
Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023
Investor Call Scheduled for Tuesday, November 21, 2023 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / November 21, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in...
Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Conference Call Scheduled for Tuesday, November 21 at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / November 20, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced t...
Peer-Reviewed Scientific Study Independently Confirms Pressure BioSciences' UltraShear Nanoemulsion Platform Vastly Outperforms Current Technologies, Delivering CBD with Unprecedented Speed, Efficiency, Reliability, and Bioavailability
World-Renowned Researchers Validate that UltraShear-Processed CBD Nanoemulsions Deliver CBD with Absorption Speed and 4X Bioavailability in Bloodstream vs. Existing Edible CBD Consumer Products SOUTH ...
Pressure BioSciences' Patented BaroFold Technology Platform for High Efficiency Biopharmaceuticals Manufacturing Featured at International Bioprocess Conference by Leading Global Contract Biologics Manufacturer
Scientists at Lonza Biologics and Pressure BioSciences Presented PBIO's Patented BaroFold Platform for Breakthrough Efficiency and Economics Versus Current Manufacturing Methods in the Nearly $500 Bil...
Pressure BioSciences Announces Exclusive Distribution Agreement with One of India's Premier Distributors of Lab Automation, Instruments, and Consumables
Bioscreen Instruments Launches Distribution of PBIO's PCT Instruments and Consumables into Third Largest Pharmaceutical and Largest Global Supply Sectors of Generic Medicines Worldwide; Expects Strong...
Pressure BioSciences Continues Expansion of IP Portfolio of Revolutionary UltraShear Technology with Award of First Canadian Patent
Patent Protects PBIO's Exclusive Rights to Commercialize UltraShear Platform in Canada, Leveraging Unique, Best-in-Class Nanoemulsions Processing Performance with Full Commercial Scalability SOUTH EAS...
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately
PBIO Acknowledges Rapidly Emerging Demand Potential for UltraShear Nanoemulsions for Transformation of Diverse Major Markets, with Recently Announced Readiness and Scaling Plans SOUTH EASTON, MA / ACC...
Pressure BioSciences Fulfillment of UltraShear Nano-CBD Orders is Underway; Customer Shipments Begin First Week of October
Further Innovations Announced, with All Systems Go for Fulfilling Current and Future Orders; UltraShear is No Longer Just the Name of a Patented, Revolutionary, One-of-a Kind Nanoemulsification Proces...
Pressure BioSciences' BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. Organization
Patented BaroFold Platform is Critical Enabler for Biopharma Manufacturing and Quality Assurance; Company Believes Future BaroFold Equipment and Recurring Utilization/Support Fees Should Exceed $100 M...
Pressure BioSciences Provides Second Progress Report on UltraShear Nano-CBD Launch and Commercialization Program "Drive to 420!"
Additional Five Customers Committed to Distributing PBIO's Best-in-Class UltraShear Nano-CBD, Representing Nearly 350 Retailers and Over $200K Incremental 2023 Sales SOUTH EASTON, MA / ACCESSWIRE / Au...
Pressure BioSciences, Inc. Reports Q2 2023 Financial Results, Provides Business Update, and Offers Guidance for 2nd Half 2023
Investor Call Scheduled for Tuesday, August 22, 2023 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / August 22, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the...
Pressure BioSciences Invites Interested Investors to Attend a Webinar on the Health and Wellness Marvels of PBIO's Revolutionary UltraShear Platform
Webinar Scheduled for 11:00AM ET on Thursday, August 17; Nearly 500 Registrants to Date. SOUTH EASTON, MA / ACCESSWIRE / August 17, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Compa...
Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD Orders
Since Mid-July Launch into Aggressive Expansion Phase, Company Adds Five New U.S. Distributors and Secures Initial Market-Seeding Orders for Over $300,000 of Revolutionary UltraShear Nano-CBD Product ...
Pressure BioSciences and Master Distributor Canopy CBD Farms Announce Major Increase in UltraShear Nanoemulsion Platform Pipeline
Rapid Q3/Q4 2023 Sales Growth Forecasted from North American Cannabis Retailers and Wholesalers SOUTH EASTON, MA / ACCESSWIRE / July 26, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "...
Pressure BioSciences Launches Program to Evaluate Company's Patented UltraShear Process in Breakthrough Application to Extend Shelf-Life of Fresh Produce
Scientific Publications Demonstrate Effectiveness of CBD and Essential Oil Nanoemulsions in Shelf-Life Extension of Fruits and Vegetables; PBI Initiating Studies with Industrially Scalable UltraShear ...
Pressure BioSciences Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering
During Interview with "Cannabis Talks" (Cannabis and Hemp Insider), CEO Ric Schumacher Reveals Transition into Aggressive Growth Phase for Revolutionary Nano-CBD with U.S. Retailers and Wholesalers SO...
Pressure BioSciences Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Crème de Canna
PBIO Adds CA Based Cannabis Quality, Innovation, and Social Equity Leader Crème de Canna to List of Distributors Selling PBIO's Ultra-Fast Acting and Highly Effective All-Natural Nano-CBD Topical Spra...
Key Academic Publication Further Validates Pressure BioSciences UltraShear Platform's Impact in Clean-Label Functional Foods & Beverages
Critical Enabling Role for UltraShear Processing in the Burgeoning Alternative Plant-Based and Ready-to-Drink Beverage Markets Highlighted in Published Study by The Ohio State University SOUTH EASTON,...
Pressure BioSciences Announces Agreement with Somalab Int'l for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products
Somalab to Enhance Existing and New Products with PBIO's UltraShear Platform. Somalab to Immediately Begin Distribution of PBIO's Best-in-Class Nano-CBD Topical Spray.
Third Round of Consumer Testing Strongly Validates Rapid Absorption and Effectiveness of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
25 Consumers Affirm UltraShear Nano-THC Spray Produces Desired Fast Initial and Max Effects, No Lung/Health Concerns from Smoke/Vape, and No Delayed and/or Impatient Excess Dosing from Edibles REMINDE...
Pressure BioSciences Invites Stakeholders, Fund Managers, and Investors to Attend a Webinar on PBIO's Revolutionary UltraShear Technology Platform
Webinar Scheduled for 4:30PM EST on Tuesday, June 27; Over 1,900 Registrants to Date. SOUTH EASTON, MA / ACCESSWIRE / June 26, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"),...
Pressure BioSciences Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products
VST Mission is to Serve Current and Past Members of US Armed Services and Coast Guard Through World-Class, Highly Effective, and Natural Wellness Products that Benefit the Mind, Body, and Soul SOUTH E...